Atlas Trials

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

Clinical trial NCT00252811 · WITHDRAWN

Trial details

NCT number
NCT00252811
Sponsor
AstraZeneca
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.